Smith & Nephew SNATS - 20 Year Stock Price History | SNN

Historical daily share price chart and data for Smith & Nephew SNATS since 1999 adjusted for splits. The latest closing stock price for Smith & Nephew SNATS as of November 12, 2019 is 42.26.
  • The all-time high Smith & Nephew SNATS stock closing price was 48.59 on September 26, 2019.
  • The Smith & Nephew SNATS 52-week high stock price is 48.93, which is 15.8% above the current share price.
  • The Smith & Nephew SNATS 52-week low stock price is 35.39, which is 16.3% below the current share price.
  • The average Smith & Nephew SNATS stock price for the last 52 weeks is 41.74.
Smith & Nephew SNATS Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 42.3981 36.4000 48.5900 35.5100 42.2600 13.06%
2018 36.3446 34.9000 39.4400 32.4000 37.3800 6.77%
2017 34.1090 29.9900 38.5000 29.9000 35.0100 16.39%
2016 32.3880 34.8000 35.0600 27.1100 30.0800 -15.51%
2015 35.0108 35.9500 37.7800 32.4800 35.6000 -3.10%
2014 32.9098 28.3360 38.9080 28.3360 36.7400 28.03%
2013 24.0164 22.2920 28.7400 21.1600 28.6960 29.49%
2012 20.3023 19.5560 22.4640 18.0520 22.1600 15.06%
2011 20.5597 21.0400 24.0760 16.8680 19.2600 -8.37%
2010 19.1278 20.6520 21.5760 16.5160 21.0200 2.54%
2009 15.8762 13.0400 20.5520 12.2280 20.5000 58.67%
2008 21.6752 23.0520 27.4280 12.1560 12.9200 -43.75%
2007 24.1161 20.9480 27.1080 20.8280 22.9680 9.73%
2006 17.8203 18.9440 21.0600 14.7800 20.9320 12.90%
2005 19.1965 20.3320 21.1320 16.1040 18.5400 -10.45%
2004 19.6518 16.7360 23.2000 16.3200 20.7040 23.47%
2003 13.2164 12.3720 16.9200 10.7200 16.7680 36.55%
2002 11.5938 12.0600 12.7820 9.6800 12.2800 0.99%
2001 9.9700 9.2000 12.1800 8.3700 12.1600 31.83%
2000 7.9306 8.2180 9.2240 6.1403 9.2240 12.01%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $18.588B $4.904B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.090B 27.01
Medtronic (MDT) Ireland $143.599B 20.16
Stryker (SYK) United States $74.738B 25.13
Boston Scientific (BSX) United States $56.464B 26.65
Baxter (BAX) United States $40.084B 24.31
EssilorLuxottica Societe Anonyme (ESLOY) France $32.664B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.619B 18.58
Terumo (TRUMY) Japan $27.722B 0.00
Lonza Group Ag (LZAGY) Switzerland $25.691B 0.00
Coloplast (CLPBY) Denmark $25.121B 0.00
ResMed (RMD) United States $20.684B 38.16
Sunny Optical Technology (SNPTF) China $18.592B 0.00
Bio-Rad Laboratories (BIO) United States $10.550B 50.64
Insulet (PODD) United States $10.476B 498.41
Canopy Growth (CGC) Canada $7.475B 0.00
Hill-Rom Holdings (HRC) United States $6.947B 20.47
Perrigo (PRGO) Ireland $6.812B 12.70
William Demant Holdings (WILYY) Denmark $6.665B 0.00
DiaSorin S.p.A (DSRLF) Italy $6.420B 0.00
Haemonetics (HAE) United States $6.037B 40.79
GN STORE NORD (GNNDY) Denmark $5.276B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $5.155B 0.00
Aurora Cannabis (ACB) Canada $3.920B 0.00
NuVasive (NUVA) United States $3.757B 29.59
ICU Medical (ICUI) United States $3.456B 22.41
GW Pharmaceuticals (GWPH) United Kingdom $3.380B 0.00
Neogen (NEOG) United States $3.369B 56.38
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.987B 0.00
Quidel (QDEL) United States $2.480B 23.54
National Vision Holdings (EYE) United States $2.179B 49.55
Agios Pharmaceuticals (AGIO) United States $1.976B 0.00
Cardiovascular Systems (CSII) United States $1.570B 0.00
InMode (INMD) Israel $1.293B 0.00
Aphria (APHA) $1.275B 0.00
VAREX IMAGING (VREX) United States $1.245B 28.70
AtriCure (ATRC) United States $1.109B 0.00
Phibro Animal Health (PAHC) United States $0.936B 17.53
Eagle Pharmaceuticals (EGRX) United States $0.863B 22.01
Lantheus Holdings (LNTH) United States $0.842B 21.04
NanoString Technologies (NSTG) United States $0.826B 0.00
TG Therapeutics (TGTX) United States $0.775B 0.00
Omeros (OMER) United States $0.669B 0.00
LeMaitre Vascular (LMAT) United States $0.662B 37.49
PetIQ (PETQ) United States $0.655B 16.01
HEXO (HEXO) $0.604B 0.00
Quanterix (QTRX) United States $0.589B 0.00
Cerus (CERS) United States $0.577B 0.00
Organigram Holdings (OGI) Canada $0.572B 0.00
OraSure Technologies (OSUR) United States $0.529B 31.74
Surmodics (SRDX) United States $0.527B 54.97
Owens & Minor (OMI) United States $0.454B 16.79
MacroGenics (MGNX) United States $0.404B 0.00
Utah Medical Products (UTMD) United States $0.383B 27.79
BioLife Solutions (BLFS) United States $0.341B 104.75
Meridian Bioscience (VIVO) United States $0.337B 11.62
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.328B 0.00
Zynex (ZYXI) United States $0.295B 33.33
Viemed Healthcare (VMD) United States $0.266B 0.00
Bovie Medical (APYX) United States $0.238B 0.00
United Health Products (UEEC) United States $0.185B 0.00
Vapotherm (VAPO) United States $0.183B 0.00
Repro-Med Systems (KRMD) United States $0.172B 0.00
Cytosorbents (CTSO) United States $0.149B 0.00
InfuSystems Holdings (INFU) United States $0.142B 0.00
Liberty Health Sciences (LHSIF) Canada $0.133B 0.00
Female Health (VERU) United States $0.131B 0.00
Fonar (FONR) United States $0.126B 8.87
Rockwell Medical (RMTI) United States $0.118B 0.00
Chimerix (CMRX) United States $0.101B 0.00
United-Guardian (UG) United States $0.085B 21.62
Chembio Diagnostics (CEMI) United States $0.080B 0.00
Nephros (NEPH) United States $0.072B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
MRI Interventions (MRIC) United States $0.053B 0.00
Surface Oncology (SURF) United States $0.048B 0.00
MTech Acquisition (KERN) United States $0.046B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.020B 0.00
Senestech (SNES) United States $0.019B 0.00
Myomo (MYO) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Akers Biosciences Inc (AKER) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00